Safety monitoring in the vaccine adverse event reporting system (VAERS)
TT Shimabukuro, M Nguyen, D Martin, F DeStefano - Vaccine, 2015 - Elsevier
Abstract The Centers for Disease Control and Prevention (CDC) and the US Food and Drug
Administration (FDA) conduct post-licensure vaccine safety monitoring using the Vaccine …
Administration (FDA) conduct post-licensure vaccine safety monitoring using the Vaccine …
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction
Since the early 1800s vaccines have saved numerous lives by preventing lethal infections.
However, during the past two decades, there has been growing awareness of possible …
However, during the past two decades, there has been growing awareness of possible …
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
EA Joura, AR Giuliano, OE Iversen… - … England Journal of …, 2015 - Mass Medical Soc
Background The investigational 9-valent viruslike particle vaccine against human
papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6 …
papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6 …
[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)
LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …
Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in …
Objective To assess the risk of serious adverse events after vaccination of adolescent girls
with quadrivalent human papillomavirus (qHPV) vaccine. Design Register based cohort …
with quadrivalent human papillomavirus (qHPV) vaccine. Design Register based cohort …
[BOOK][B] Deadly choices: How the anti-vaccine movement threatens us all
PA Offit - 2015 - books.google.com
Page 1 “The very best antidote to vaccine-related misinformation: the writings of vaccinologist
Paul Offit. No one is better at reducing anti-vaccine claims to intellectual rubble.” —New …
Paul Offit. No one is better at reducing anti-vaccine claims to intellectual rubble.” —New …
Present status of human papillomavirus vaccine development and implementation
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …
Safety of human papillomavirus vaccines: an updated review
Human papillomavirus (HPV) vaccines are now included in immunisation programmes in 71
countries. Unfortunately, uptake has been impacted in some countries by reduced …
countries. Unfortunately, uptake has been impacted in some countries by reduced …
[HTML][HTML] Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation
Objective Human papillomavirus (HPV) vaccine uptake in many countries has been sub-
optimal. We examine several issues associated with non-vaccination that have received …
optimal. We examine several issues associated with non-vaccination that have received …
An overview of quadrivalent human papillomavirus vaccine safety: 2006 to 2015
M Vichnin, P Bonanni, NP Klein… - The Pediatric …, 2015 - journals.lww.com
Background: A quadrivalent human papillomavirus (HPV4) type 6/11/16/18 vaccine
(GARDASIL/SILGARD®) has been licensed in many countries around the world for the …
(GARDASIL/SILGARD®) has been licensed in many countries around the world for the …